Prenosis, Inc. made a significant announcement on Wednesday regarding the FDA's marketing authorization for their AI SaMD tool called Sepsis ImmunoScore through the De Novo pathway.
/PRNewswire/ Prenosis, Inc., an artificial intelligence company enabling precision medicine for abnormal immune responses in acute care, announced today the.
/PRNewswire/ Prenosis, Inc., a precision medicine company, today announced four new members to its Board of Directors and nine members to its Clinical &.
Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes.